DV
Dividend Vision

ALKS — Alkermes plc

Alkermes plc (ALKS)

Its deepest 1-year drawdown was 22.2%.

Alkermes plc is a single-stock equity holding in a biopharmaceutical company focused on developing and commercializing medicines for mental illness and substance use disorders. The stock does not currently pay a dividend, so there is no yield profile or distribution frequency. This holding appeals primarily to growth-oriented investors rather than income-focused investors seeking dividend exposure.

ALKS key facts

Asset type
Stock
Asset class
Equity
Inception date
07/16/1991
Distribution frequency
None
Last close
$49.06
Market cap
$8,230,466,048
Average volume
1267800.0
Beta
0.268
Payout ratio
0.0
P/E ratio
129.1053
Forward P/E
133.3333
EPS
$0.38